Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
B74-C52H8 | Canine | Canine B7-H4 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
B74-R52H9 | Rat | Rat B7-H4 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
B74-C52H9 | Cynomolgus/Rhesus | Cynomolgus / Rhesus B7-H4 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
B74-M52H9 | Mouse | Mouse B7-H4 Protein, His Tag | ![]() |
![]() ![]() |
|
B74-H5256 | Human | Human B7-H4 Protein, Fc Tag, low endotoxin | ![]() |
![]() ![]() |
![]() ![]() |
B74-H82E2 | Human | Biotinylated Human B7-H4 Protein, Avitag™,His Tag (recommended for biopanning) | ![]() |
![]() ![]() |
![]() ![]() |
B74-H8222 | Human | Biotinylated Human B7-H4 Protein, His Tag, ultra sensitivity (primary amine labeling) | ![]() |
![]() ![]() |
![]() ![]() |
B74-H5222 | Human | Human B7-H4 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
Immobilized Cynomolgus / Rhesus B7-H4, His Tag (Cat. No. B74-C52H9) at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Human B7-H4 Antibody, Human IgG1 with a linear range of 0.1-8 ng/mL (QC tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
NC-762 | NC-762 | Phase 2 Clinical | Ovarian Neoplasms; Solid tumours; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung | Details | |
GEN-1047 | GEN-1047 | Phase 2 Clinical | Genmab A/S | Ovarian Neoplasms; Carcinoma; Breast Neoplasms; Uterine Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms | Details |
Alsevalimab | FPA-150 | Phase 1 Clinical | Five Prime Therapeutics | Solid tumours; Ovarian Neoplasms; Carcinoma, Transitional Cell; Urinary Bladder Neoplasms; Breast Neoplasms; Endometrial Neoplasms | Details |
SGN-B7H4V | SGN-B-7H-4V; SGNB-7H4V; SGNB-7H-4V; SGN-B7H4V | Phase 1 Clinical | Seagen Inc | Ovarian Neoplasms; Cholangiocarcinoma; Breast Neoplasms; Peritoneal Neoplasms; Gallbladder Neoplasms; Fallopian Tube Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
PF-07260437(Pfizer) | PF-07260437 | Phase 1 Clinical | Pfizer Inc | Ovarian Neoplasms; Breast Neoplasms; Endometrial Neoplasms | Details |
This web search service is supported by Google Inc.